A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Respiratory Syncytial Virus Prefusion F Subunit Vaccine When Coadministered with Seasonal Inactivated Influenza Vaccine in Adult

Status	Active
Effective start/end date	20/02/22 → 28/02/25

Project Details